- Home
- PTCT vs QLYS Comparison
PTCT vs QLYS Comparison
Compare PTCT & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- QLYS
- Stock Information
- Founded
- PTCT 1998
- QLYS 1999
- Country
- PTCT United States
- QLYS United States
- Employees
- PTCT N/A
- QLYS N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- QLYS Computer Software: Prepackaged Software
- Sector
- PTCT Health Care
- QLYS Technology
- Exchange
- PTCT Nasdaq
- QLYS Nasdaq
- Market Cap
- PTCT 3.9B
- QLYS 4.4B
- IPO Year
- PTCT 2013
- QLYS 2012
- Fundamental
- Price
- PTCT $48.55
- QLYS $135.83
- Analyst Decision
- PTCT Buy
- QLYS Hold
- Analyst Count
- PTCT 14
- QLYS 17
- Target Price
- PTCT $63.57
- QLYS $137.36
- AVG Volume (30 Days)
- PTCT 1.1M
- QLYS 314.5K
- Earning Date
- PTCT 08-07-2025
- QLYS 08-05-2025
- Dividend Yield
- PTCT N/A
- QLYS N/A
- EPS Growth
- PTCT N/A
- QLYS 13.46
- EPS
- PTCT 7.51
- QLYS 4.89
- Revenue
- PTCT $1,772,758,000.00
- QLYS $621,665,000.00
- Revenue This Year
- PTCT $121.50
- QLYS $9.64
- Revenue Next Year
- PTCT N/A
- QLYS $6.65
- P/E Ratio
- PTCT $6.45
- QLYS $27.73
- Revenue Growth
- PTCT 91.12
- QLYS 9.14
- 52 Week Low
- PTCT $29.02
- QLYS $112.61
- 52 Week High
- PTCT $58.38
- QLYS $170.00
- Technical
- Relative Strength Index (RSI)
- PTCT 46.94
- QLYS 42.35
- Support Level
- PTCT $47.52
- QLYS $146.76
- Resistance Level
- PTCT $49.73
- QLYS $151.10
- Average True Range (ATR)
- PTCT 1.46
- QLYS 3.30
- MACD
- PTCT -0.19
- QLYS -0.60
- Stochastic Oscillator
- PTCT 36.28
- QLYS 11.55
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.